Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins be Key Mediators of this Association?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|15|1|38-46

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.15, Iss.1, 2014-06, pp. : 38-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beyond Low-Density Lipoprotein: Addressing the Atherogenic Lipid Triad in Type 2 Diabetes Mellitus and the Metabolic Syndrome

By Nesto Richard W.  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 379-387

Adis International

Access to resources Recommend Favorite

Mediterranean Diet Rich in Olive Oil and Obesity, Metabolic Syndrome and Diabetes Mellitus

By  

Current Pharmaceutical Design, Vol. 17, Iss. 8, 2011-03 ,pp. : 769-777

Bentham Science Publishers

Access to resources Recommend Favorite

The Genetics of Obesity and the Metabolic Syndrome

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 10, Iss. 2, 2010-06 ,pp. : 86-108

Bentham Science Publishers

Access to resources Recommend Favorite

Association Between Polycystic Ovary Syndrome and Metabolic Syndrome

By  

Current Medicinal Chemistry, Vol. 21, Iss. 35, 2014-11 ,pp. : 3999-4012

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 15, Iss. 29, 2009-10 ,pp. : 3446-3462

Bentham Science Publishers

Access to resources Recommend Favorite